News from MedImmune

Nov 13, 2013, 10:17 ET

MedImmune Specialty Care And Author Elizabeth Pantley Publish "A Parent's Guide to Flu Season"

 Today, MedImmune Specialty Care division of AstraZeneca (MedImmune Specialty Care) announced its partnership with Elizabeth Pantley, author of...

Oct 07, 2013, 12:45 ET
Support Metastatic Breast Cancer Awareness Day Oct. 13: MyMBCStory.com/awareness.  (PRNewsFoto/MedImmune Specialty Care Division of AstraZeneca)

New Interactive Tools Empower Women to Express Selves, Raise Awareness on October 13 - Metastatic Breast Cancer Awareness Day

 In the U.S., approximately 159,000 women are living with metastatic breast cancer. To raise awareness of Metastatic Breast Cancer Awareness...

Sep 24, 2013, 10:55 ET
Tia Mowry receives FluMist(R) Quadrivalent (Influenza Vaccine Live, Intranasal).  (PRNewsFoto/MedImmune Specialty Care)

MedImmune Specialty Care And Actress Tia Mowry Team Up To Take On Influenza This Season

 Today, MedImmune Specialty Care division of AstraZeneca (MedImmune Specialty Care) announced it has joined with actress Tia Mowry to raise...

Jul 26, 2013, 10:01 ET

MedImmune's FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal), Four-Strain, Nasal-Spray Flu Vaccine, Ships for 2013-2014 Influenza Season

MedImmune, the global biologics research and development arm of AstraZeneca, announced today that it began shipping FluMist Quadrivalent to...

May 04, 2013, 10:00 ET

MedImmune To Present Seven Posters On Influenza, Respiratory Syncytial Virus At The Annual Pediatric Academic Societies Meeting

 MedImmune announced today it will conduct seven poster and/or presentations at the Pediatric Academic Societies (PAS) Meeting at the Walter E....

Dec 17, 2012, 09:00 ET

MedImmune Announces Agreement with Progenics Pharmaceuticals to Develop Therapies Against Serious Bacterial Infections

 MedImmune, the global biologics arm of AstraZeneca, announced that it has signed an in-licensing agreement with Progenics Pharmaceuticals,...

Oct 19, 2012, 15:00 ET

MedImmune To Present Three Influenza Abstracts At The IDWeek 2012 Meeting

 MedImmune, the global biologics arm of AstraZeneca, announced today it will present three influenza abstracts at IDWeek 2012: the first...

Oct 09, 2012, 11:30 ET

MedImmune To Present Four Flu Abstracts At The Influenza Vaccines For The World Conference

 MedImmune, the global biologics arm of AstraZeneca, announced today it will present four abstracts at the Influenza Vaccines for the World...

Oct 09, 2012, 09:00 ET

MedImmune Joins Forces With Leading Cancer Organizations to Advance Novel Immunotherapy Research

 The Cancer Research Institute (CRI), the Ludwig Institute for Cancer Research and MedImmune, the global biologics arm of AstraZeneca, today...

Oct 03, 2012, 12:30 ET

Study In Journal of Medical Economics Shows Palivizumab Cost Effectiveness Using FDA-approved Dosing And AAP Red Book

MedImmune, the biologics arm of AstraZeneca, today announced that the Journal of Medical Economics has published a study that shows Synagis®...

Sep 10, 2012, 06:00 ET

MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market

 MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outsourcing company, today announced...

Aug 02, 2012, 10:30 ET

FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping For 2012-2013 Influenza Season

MedImmune, the global biologics arm of AstraZeneca, announced it began shipping FluMist® to influenza vaccine distributors throughout the...

Jul 10, 2012, 10:00 ET

MedImmune And KaBOOM! Team Up To Build New Playground At The Children's Inn At NIH

 Summer is a time to play and July 23rd is when The Children's Inn at NIH will get a fabulous new playground thanks to the generosity of...

May 01, 2012, 10:44 ET

New Study Demonstrates Dosing Non-Compliance Increases RSV-Related Hospitalizations Among High-Risk Babies In Medicaid Population

MedImmune, the global biologics arm of AstraZeneca, announced results from a new retrospective database cohort study of 8,443 high-risk infants...

Mar 26, 2012, 10:00 ET

MedImmune to Present Nine Abstracts Related to Influenza Vaccination at First Online National Immunization Conference

MedImmune announced today it will present nine abstracts at the National Immunization Conference Online (NIC Online), from March 26 – 28,...

Feb 29, 2012, 19:20 ET

MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal)

 MedImmune today announced that the U.S. Food and Drug Administration (FDA) has approved FluMist® Quadrivalent (Influenza Vaccine Live,...

Nov 14, 2011, 11:00 ET

MedImmune Announces Winners of Its 6th Annual Global Abstract Competition

MedImmune today announced the winners of its 6th Annual Research Abstract Competition highlighting the work of the next generation of scientific...

Nov 08, 2011, 07:00 ET

MedImmune Manufacturing Facility Recognized as 2011 Facility of the Year in Pharmaceutical Engineering

MedImmune, the global biologics arm of AstraZeneca, today announced that the company's expansion project at its Frederick, Md., Manufacturing...

Nov 03, 2011, 11:19 ET

MedImmune annonce les vainqueurs de son concours européen de résumés de recherche sur le cancer

?MedImmune a dévoilé aujourd'hui les noms des lauréats de son concours européen annuel de résumés de recherche sur...

Nov 03, 2011, 11:16 ET

MedImmune annuncia i vincitori del concorso European Cancer Research Abstract Competition

?Oggi edImmune ha annunciato i vincitori del concorso European Cancer Research Abstract Competition che premia ricerche importanti condotte da...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer